Vaderis Therapeutics

Driven to discover. First to deliver.

Basel, Switzerland · Founded 2019 · $171.0M raised

Headquarters
Basel
Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$171.0M
Last Round
$152.0M Series BAug 2026
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Vaderis Therapeutics is a Basel, Switzerland-based clinical-stage biopharmaceutical company founded in 2019 to develop targeted therapies for rare vascular diseases caused by vascular malformations. Its lead candidate, engasertib, is in a global Phase 3 study called HEROIC for hereditary hemorrhagic telangiectasia (HHT), and the company closed an oversubscribed $152 million Series B in August 2026 co-led by Goldman Sachs Alternatives and TCGX.

Summary

Vaderis Therapeutics is a Biotech company based in Basel, Switzerland, founded in 2019. It has raised $171.0M in total across 3 rounds, most recently a $152.0M Series B round in Aug 2026. Investors include Medicxi and TCGX.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BAug 2026
$152.0M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vaderis Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/vaderis-therapeutics"><img src="https://indexed.vc/api/badge/company/vaderis-therapeutics" alt="Vaderis Therapeutics on Indexed.vc" width="260" height="76" /></a>